|
HS Code |
191282 |
| Product Name | 4-Bromo-6-Methoxyquinoline |
| Cas Number | 219909-65-6 |
| Molecular Formula | C10H8BrNO |
| Molecular Weight | 238.08 |
| Appearance | Solid, usually light yellow to brown |
| Melting Point | 103-106°C |
| Solubility | Soluble in organic solvents like DMSO, methanol |
| Purity | Typically >97% |
| Smiles | COC1=CC2=NC=CC(=C2C=C1)Br |
| Inchi | InChI=1S/C10H8BrNO/c1-13-7-5-8-9(6-10(7)11)3-2-4-12-8/h2-6H,1H3 |
| Storage Condition | Store at 2-8°C, keep container tightly closed |
As an accredited 4-Bromo-6-Methoxyquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-6-Methoxyquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Bringing new chemicals into the lab isn’t just about ticking boxes on a list. It’s about making choices that drive accuracy, safety, and creativity in research and industry. 4-Bromo-6-Methoxyquinoline stands out in the world of fine chemicals for those who know their way around organic synthesis, drug discovery, and material science. For years, chemists and technical specialists have combed through bulky catalogs searching for quinoline derivatives that promise both performance and dependability. It’s rare to come across a compound that offers targeted selectivity, stability, and flexibility for a wide field of scientific work. From the first time I handled quinoline derivatives in an academic lab, I realized how much hinges on purity and reliability—two things that shape every reaction and every outcome.
The backbone of 4-Bromo-6-Methoxyquinoline—a quinoline ring, with a bromine atom at position four and a methoxy group at position six—might sound straightforward to those familiar with aromatic chemistry. But these substituents fundamentally reshape how this compound behaves when put to work. The bromine atom changes the electron distribution and affects reactivity, making the molecule a useful intermediate in halogenation and cross-coupling reactions. On the other hand, the methoxy group doesn’t just sit idle; its electron-donating nature tweaks reactivity in ways that chemists can exploit to open doors for selective transformations. After handling dozens of similar heterocycles, I’ve seen how a single substituent—a bromine here, a methoxy there—alters everything from solubility to reaction path, letting researchers fine-tune outcomes in ways not possible with unsubstituted quinolines.
Every lab project comes with its own list of challenges. What sets 4-Bromo-6-Methoxyquinoline apart is its versatility across academic research, industrial scale-ups, and specialty chemical production. In organic synthesis, this compound helps unlock tricky transformations that simple quinoline or monohalogenated versions just don’t handle as cleanly. Many in medicinal chemistry use bromo-substituted quinolines to build more complex bioactive molecules. The compound serves as a robust starting point for Suzuki, Heck, and Sonogashira coupling reactions—processes that demand both reactivity and selectivity from their building blocks.
A story comes to mind from several years back. In the push to create new kinase inhibitors, a peer in pharma R&D shared how their screens kept hitting dead ends with conventional quinolines—yields tanked, byproducts crept in, and the process needed costly downstream purification. By switching to 4-Bromo-6-Methoxyquinoline, they accessed key substitution points under milder conditions. They reported higher yields, cleaner reactions, and a definite cut in purification headaches. Their team went on to file a patent that cited this compound as a critical intermediate. Cases like this aren’t one-offs; they reflect industry-wide trends. With so much time and investment at stake, reliable core structures matter.
Anyone who has worked with quinolines knows there’s no such thing as “one size fits all.” Each substitution brings new possibilities and pain points. Simple quinoline, though abundant and cheap, doesn’t offer much in the way of functional handles for further functionalization. 4-bromoquinoline delivers a platform for palladium-catalyzed couplings, but often requires harsher conditions or offers less selectivity for especially sensitive substrates. The addition of a methoxy group at position six in 4-Bromo-6-Methoxyquinoline introduces a new level of control in reactivity, shifting electron density and steering subsequent reactions with greater finesse.
I remember comparing reaction outcomes between 4-bromoquinoline and its methoxy derivative in a late-stage arylation project. Under identical conditions, the methoxy version outperformed its simpler cousin—yielding the desired product while keeping side-reactions in check. The analytical data always spoke volumes: fewer impurities, less time wasted on column chromatography, and far less frustration on late nights in the lab.
Consistency matters in fine chemical supply. Labs and production lines can’t afford to pause because a batch failed to meet its mark. 4-Bromo-6-Methoxyquinoline, when sourced from a reputable supplier and handled properly, tends to show tight control over purity levels—often above 98% or higher. Such tight specs make a world of difference in both routine lab work and scale-up processes. An unanticipated impurity does more than just show up on an HPLC trace; it can throw an entire synthesis off course, costing days of work and valuable resources.
Quality isn’t just about a certificate of analysis. Behind every successful application of this quinoline stands technical support, well-maintained supply chains, and deep product documentation. As a researcher, I’ve leaned on those data sheets and purity checks more times than I can count. Finding a compound that delivers lot-to-lot consistency with thorough analytical backing—NMR, HPLC, and mass spectrometry profiles—has saved more than a few projects from collapse.
Safety is the unwritten backbone of all chemical work. 4-Bromo-6-Methoxyquinoline, like many aromatic halides, requires careful handling. Fume hood use, protective clothing, and good hygiene anchor safe work habits. This isn’t just box-ticking; it’s a daily reality for anyone who has faced a lab spill or unexpected reaction. Solubility in common organic solvents like dichloromethane, ethanol, or acetonitrile means researchers can tailor the medium to their task, but it also calls for respect for chemical compatibility and waste disposal. Years of lab experience have drilled it into me: no shortcut ever paid off when safety was on the line.
Storage presents its own set of requirements. Keeping the product away from moisture and direct light extends its lifetime and keeps degradation from becoming a problem. Fluctuating warehouse conditions—swings in humidity or temperature—affect sensitive reagents. Anyone storing these compounds for long-term work comes to appreciate airtight containment and proper labeling. I learned early in my career that skipping over careful storage not only risks product spoilage but also introduces confusion down the road, especially with similar-looking high-purity powders.
Drug research and development moves fast and rewards those who can adapt on the fly. 4-Bromo-6-Methoxyquinoline has found an audience with researchers designing new antiviral, antibacterial, and anticancer agents. Substituted quinolines appear in a range of pharmacologically active molecules. The dual substituents—bromine and methoxy—open doors for synthesizing novel compounds with potential therapeutic effects. As pipelines become more crowded, the pressure to generate unique chemical scaffolds increases. Flexible intermediates like this quinoline derivative help answer that need, offering points of attachment for further chemical creativity.
Clinical-stage projects often hinge on the ability to make subtle changes that affect not just efficacy but also safety and metabolic stability. Medicinal chemists rarely look for blanket solutions; subtlety brings the best results. During one project on kinase inhibitors, a colleague noticed marked improvements in selectivity and metabolic profile with molecules derived from 4-Bromo-6-Methoxyquinoline. These seemingly minor differences in starting materials sometimes mean the difference between a patentable drug candidate and a failed project.
The journey from hit to lead to candidate stretches over months or even years. A single reliable building block can accelerate this process. With regulatory expectations rising and pressure to reduce animal studies and waste, having a tried-and-true quinoline intermediate in the toolbox simplifies compliance and reporting. Quality records, detailed traceability, and clear documentation aren’t just for show—they keep every step transparent and help teams stay ready for future audits or submissions.
Chemical research never stands still. Each year brings new synthetic methods, tighter purity demands, and greater scrutiny of environmental impact. Certain industries—pharmaceuticals, agrochemicals, and advanced materials—have raised the bar on both performance and sustainability. 4-Bromo-6-Methoxyquinoline answers the call for reliable heterocyclic intermediates that fit evolving standards. With green chemistry principles gaining traction, every reaction step comes under review for waste, atom economy, and hazardous reagents. Careful substitution patterns can allow for milder, less toxic routes to final products.
Waste solution management weighs on every lab budget and environmental audit. Compounds that work at lower catalyst loadings or under milder conditions mean less waste and less risk to personnel and the environment. At a recent scientific conference, several speakers highlighted how modified quinolines could deliver tailored performance in crop protection or imaging agents, all while complying with red tape and shifting regulatory requirements. Having an intermediate that fits inside such frameworks goes from “nice to have” to “must-have.”
Collaboration drives the best discoveries. Universities, startups, and industrial partners often come together on projects where time and experimental reliability make or break results. 4-Bromo-6-Methoxyquinoline has made its way into shared protocols and distributed research programs thanks to its predictable performance. In graduate seminars, the compound appears among case studies on successful structure-activity relationship work. Faculty members cite it when discussing ways to accelerate chemical space exploration, a theme echoed in grant proposals and multi-year research plans.
Shared experience in lab groups often brings up stories of rescue by a reliable intermediate. During my own postdoctoral research, one recurring theme centered on shifting to higher-purity quinolines at key steps. Results tightened up. NMR spectra looked crisper, and project timelines shrank. The cost of investing in a well-characterized compound paled next to the savings in troubleshooting later. Teams also valued clear supply agreements and chemical traceability—nothing derails a collaboration faster than uncertainties over source material or mismatched lot numbers.
New products bring hope and, sometimes, anxiety. Reliability issues, variable yields, and compliance headaches can drag down even inspired research. 4-Bromo-6-Methoxyquinoline shows that careful selection of starting materials can head off such problems. Experienced chemists look beyond isolated yield figures and weigh the practicalities—supplier support, shipping stability, and ability to scale without losing quality.
Clear communication between vendors and users goes a long way. Technical bulletins and batch-specific data put power back in the hands of end-users, reducing troubleshooting time and making it easier to replicate results. Over the years, I’ve learned that a culture of transparency—sharing batch data, impurity profiles, and synthesis traceability—builds trust across the chemical supply ecosystem. 4-Bromo-6-Methoxyquinoline has benefited from this trend, with technical documentation that doesn’t just check regulatory boxes, but helps project teams get things right on the first try.
Labs trying to keep pace with shifting project needs often struggle with uncertainty in their inputs. Chemical purity, consistent supply, and technical support go hand in hand. The best suppliers respond quickly to changing requests, adjust packages to fit project requirements, and back up their shipments with the data that matters. I once worked with a team scaling an academic synthesis to pilot level—they ran into trouble with inconsistent properties from different batches of a supposed “identical” compound sourced on the open market. Swapping in a trusted, documented batch of 4-Bromo-6-Methoxyquinoline restored order. The project moved forward on schedule, their grant funding stayed intact, and no corners were cut just to keep timelines.
Efficient workflow depends on more than bottles and vials; it’s built on relationships and shared standards. The steady performance of quinoline derivatives like this bromo-methoxy compound makes it easier for entire organizations—big and small—to stay on track and meet targets. Customers talk about time saved, reduced troubleshooting, and the ability to push their synthetic efforts in new directions, all made possible by robust building blocks that do just what they are supposed to: perform under demanding conditions.
The path through chemical development rarely runs smoothly, but picking the right tools makes a world of difference. 4-Bromo-6-Methoxyquinoline, with its unique substitution pattern and proven track record in modern chemistry, offers practical answers to real problems faced by researchers across industries. Every batch, every project, and every discovery depends on a foundation of quality and open communication. Those values have steered discussions at industry panels, shaped contracts with suppliers, and defined the day-to-day operations of successful research teams.
In the end, experience shows that the smallest choices can set the biggest projects on the right track. Thoughtful selection and responsible handling of key intermediates like 4-Bromo-6-Methoxyquinoline guide scientific discovery from bench to market, making sure hard-won insights translate into real-world results.